Cargando…
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
Data describing the effect of in vivo B cell depletion on general bone loss in patients with rheumatoid arthritis (RA) are limited. Given the pathogenetic role of B cells in RA, it is tempting to speculate that B cell depletion might have a beneficial effect on bone loss. We prospectively investigat...
Autores principales: | Wheater, Gillian, Elshahaly, Mohsen, Naraghi, Kamran, Tuck, Stephen P., Datta, Harish K., van Laar, Jacob M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078302/ https://www.ncbi.nlm.nih.gov/pubmed/30080871 http://dx.doi.org/10.1371/journal.pone.0201527 |
Ejemplares similares
-
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
por: Elshahaly, Mohsen, et al.
Publicado: (2013) -
The clinical utility of bone marker measurements in osteoporosis
por: Wheater, Gillian, et al.
Publicado: (2013) -
Bone marker reference range study: a comparison of the manufacturer’s reference range and laboratory healthy volunteer results to patients with rheumatoid arthritis
por: Wheater, Gillian, et al.
Publicado: (2013) -
The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies
por: Roodenrijs, Nadia M. T., et al.
Publicado: (2018) -
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)